| Diag |
Description |
% Cases |
Mortality |
Morbidity |
Complications |
| Rate |
Factors |
FIT |
Rate |
Factors |
FIT |
Rate |
Factors |
FIT |
| 507 |
Pneumonitis due to solids/liquids |
0.45% |
13.2% |
27 |
0.119 |
27.1% |
48 |
0.384 |
59.3% |
50 |
0.317 |
| 511 |
Pleurisy |
0.16% |
3.8% |
22 |
0.113 |
21.7% |
30 |
0.404 |
56.6% |
33 |
0.283 |
| 512 |
Pneumothorax |
0.11% |
2.5% |
20 |
0.151 |
9.4% |
27 |
0.436 |
32.3% |
30 |
0.342 |
| 515 |
Fibrosis postinflammatory pulmonary |
0.07% |
7.0% |
21 |
0.132 |
21.9% |
26 |
0.442 |
47.6% |
34 |
0.335 |
| 518 |
Diseases, lung, other |
1.03% |
18.0% |
42 |
0.200 |
41.0% |
48 |
0.410 |
69.7% |
66 |
0.356 |
| 531 |
Ulcer, gastric |
0.23% |
2.2% |
23 |
0.159 |
12.2% |
41 |
0.455 |
52.2% |
48 |
0.308 |
| 532 |
Ulcer, duodenal |
0.16% |
3.6% |
26 |
0.160 |
14.4% |
35 |
0.479 |
52.9% |
46 |
0.326 |
| 535 |
Gastritis and duodenitis |
0.31% |
0.6% |
20 |
0.045 |
8.7% |
30 |
0.213 |
42.5% |
41 |
0.242 |
| 540 |
Appendicitis, acute |
0.68% |
0.2% |
20 |
0.062 |
3.0% |
25 |
0.503 |
16.0% |
29 |
0.355 |
| 557 |
Insufficiency, vascular, intestine |
0.16% |
9.7% |
33 |
0.218 |
22.3% |
42 |
0.441 |
59.5% |
40 |
0.306 |
| 560 |
Obstruction, intestinal w/o hernia |
0.79% |
2.7% |
40 |
0.110 |
9.9% |
49 |
0.447 |
40.6% |
66 |
0.324 |
| 567 |
Peritonitis |
0.06% |
4.1% |
26 |
0.140 |
12.8% |
34 |
0.469 |
48.4% |
31 |
0.343 |
| 569 |
Disorders, intestine, other |
0.28% |
3.5% |
54 |
0.178 |
14.6% |
56 |
0.448 |
50.8% |
61 |
0.326 |
| 571 |
Disease and cirrhosis, liver, chrn |
0.26% |
8.1% |
26 |
0.176 |
18.3% |
41 |
0.371 |
57.6% |
40 |
0.283 |
| 572 |
Abscess and disease sequelae, liver |
0.14% |
8.5% |
26 |
0.192 |
17.0% |
28 |
0.433 |
54.5% |
36 |
0.303 |
| 574 |
Cholelithiasis |
0.87% |
0.6% |
37 |
0.077 |
8.2% |
40 |
0.517 |
32.5% |
56 |
0.379 |
| 577 |
Diseases, pancreas |
0.71% |
1.1% |
28 |
0.138 |
8.0% |
41 |
0.480 |
38.8% |
50 |
0.322 |
| 578 |
Hemorrhage, gastrointestinal |
0.43% |
3.8% |
23 |
0.155 |
12.5% |
44 |
0.472 |
52.9% |
43 |
0.301 |
| 584 |
Renal failure, acute |
0.91% |
5.6% |
44 |
0.107 |
19.8% |
56 |
0.411 |
53.3% |
56 |
0.319 |
| 585 |
Renal failure, chronic |
0.04% |
7.6% |
26 |
0.378 |
15.1% |
21 |
0.472 |
53.2% |
26 |
0.322 |
| 590 |
Infections, kidney |
0.31% |
0.3% |
14 |
0.024 |
6.0% |
31 |
0.353 |
25.5% |
32 |
0.346 |
| 592 |
Calculus, kidney and ureter |
0.40% |
0.1% |
15 |
0.048 |
2.6% |
35 |
0.199 |
15.2% |
31 |
0.256 |
| 599 |
Disorder, urethra/urinary tract oth |
0.92% |
1.3% |
27 |
0.027 |
10.1% |
49 |
0.380 |
32.7% |
50 |
0.288 |
| 682 |
Cellulitis and abscess, other |
1.31% |
0.4% |
28 |
0.039 |
3.6% |
41 |
0.418 |
23.6% |
63 |
0.336 |
| 707 |
Ulcer, chronic, skin |
0.17% |
2.2% |
33 |
0.063 |
10.6% |
63 |
0.422 |
45.8% |
65 |
0.362 |
| 715 |
Osteoarthrosis and allied disorders |
2.25% |
0.1% |
15 |
0.045 |
2.5% |
37 |
0.250 |
32.0% |
66 |
0.172 |
| 721 |
Spondylosis and allied disorders |
0.32% |
0.2% |
17 |
0.059 |
3.2% |
37 |
0.392 |
22.3% |
51 |
0.375 |
| 722 |
Disorders, intervertebral disc |
1.06% |
0.1% |
20 |
0.078 |
1.9% |
43 |
0.329 |
18.5% |
55 |
0.360 |
| 724 |
Disorders, back, other & unspc |
0.44% |
0.2% |
22 |
0.070 |
3.3% |
35 |
0.399 |
30.1% |
47 |
0.339 |
| 730 |
Infections involving bone |
0.14% |
0.8% |
21 |
0.061 |
8.4% |
57 |
0.462 |
38.4% |
70 |
0.381 |
| 733 |
Disorders, bone and cartilage |
0.44% |
0.9% |
34 |
0.067 |
5.7% |
43 |
0.413 |
33.7% |
66 |
0.333 |
| 780 |
Symptoms, general |
1.62% |
0.5% |
31 |
0.031 |
4.1% |
45 |
0.331 |
28.8% |
60 |
0.249 |
| 784 |
Symptoms involving head and neck |
0.15% |
0.4% |
11 |
0.032 |
4.5% |
28 |
0.434 |
32.4% |
36 |
0.290 |
| 785 |
Symptoms inv cardiovascular system |
0.07% |
3.3% |
22 |
0.390 |
8.0% |
32 |
0.621 |
39.7% |
45 |
0.357 |
| 786 |
Symptoms inv respiratory syst/chest |
2.26% |
0.1% |
21 |
0.018 |
2.0% |
41 |
0.248 |
19.3% |
49 |
0.248 |
| 787 |
Symptoms involving digestive system |
0.23% |
0.7% |
19 |
0.026 |
6.1% |
29 |
0.396 |
43.3% |
40 |
0.246 |
| 789 |
Symptoms inv abdomen, pelvis, other |
0.50% |
0.5% |
21 |
0.038 |
5.8% |
32 |
0.136 |
35.5% |
38 |
0.244 |
| 805 |
Fx, vrt column w/o spinal crd inj |
0.27% |
1.3% |
30 |
0.105 |
7.3% |
42 |
0.513 |
36.8% |
57 |
0.366 |
| 807 |
Fracture Rib/Sternum/Larynx/Trachea |
0.10% |
1.8% |
23 |
0.113 |
9.2% |
27 |
0.489 |
36.8% |
41 |
0.370 |
| 808 |
Fracture, pelvis |
0.15% |
1.4% |
24 |
0.094 |
7.6% |
33 |
0.503 |
36.3% |
43 |
0.371 |
| 851 |
Laceration and contusion, cerebral |
0.06% |
8.8% |
40 |
0.374 |
14.4% |
35 |
0.445 |
41.5% |
35 |
0.479 |
| 852 |
Hemorrhage, intracranial post-inj |
0.19% |
11.1% |
42 |
0.371 |
15.3% |
38 |
0.468 |
44.9% |
46 |
0.444 |
| 965 |
Poisoning analgesics/antirheumatics |
0.17% |
1.7% |
17 |
0.221 |
18.7% |
26 |
0.634 |
48.9% |
33 |
0.377 |
| 969 |
Poisoning by psychotropic agents |
0.20% |
0.7% |
8 |
0.139 |
17.2% |
18 |
0.644 |
45.9% |
28 |
0.378 |
| 996 |
Complication peculiar to procedures |
1.55% |
1.8% |
53 |
0.109 |
12.0% |
78 |
0.488 |
45.9% |
106 |
0.328 |
| 997 |
Complication affecting body NEC |
0.33% |
1.6% |
39 |
0.134 |
16.2% |
59 |
0.478 |
49.1% |
64 |
0.307 |
| 998 |
Complications of procedures NEC |
0.72% |
1.0% |
24 |
0.106 |
7.8% |
51 |
0.492 |
36.2% |
70 |
0.360 |
| DRG103 |
|
0.01% |
21.6% |
13 |
0.199 |
59.8% |
14 |
0.420 |
91.3% |
11 |
0.227 |
| DRG480 |
|
0.01% |
5.3% |
9 |
0.079 |
30.9% |
18 |
0.364 |
72.2% |
19 |
0.283 |
| DRG481 |
|
0.02% |
6.5% |
12 |
0.320 |
13.8% |
14 |
0.554 |
62.2% |
20 |
0.375 |
| DRG495 |
|
0.00% |
4.2% |
6 |
0.135 |
39.9% |
5 |
0.201 |
82.5% |
7 |
0.225 |
| DRG512 |
|
0.00% |
2.1% |
4 |
0.134 |
17.0% |
11 |
0.647 |
69.2% |
9 |
0.339 |
| DRG513 |
|
0.00% |
2.2% |
1 |
. |
13.0% |
8 |
0.724 |
63.6% |
5 |
0.358 |
| Femur_ |
Femur_Fracture |
0.97% |
2.5% |
38 |
0.108 |
13.7% |
48 |
0.469 |
56.7% |
60 |
0.281 |
| Hernia |
Hernia |
0.48% |
1.1% |
28 |
0.118 |
8.9% |
38 |
0.500 |
34.4% |
52 |
0.352 |
| Hyperte |
Hypertensive |
0.51% |
2.5% |
39 |
0.094 |
23.9% |
49 |
0.570 |
51.4% |
53 |
0.398 |
| Immatur |
Immature_Neonates |
1.27% |
3.0% |
16 |
0.356 |
na |
na |
na |
na |
na |
na |
| Leukemi |
Leukemia |
0.10% |
16.9% |
20 |
0.203 |
20.8% |
27 |
0.446 |
54.4% |
34 |
0.378 |
| Normal_ |
Normal_Neonates |
9.66% |
0.1% |
23 |
0.009 |
na |
na |
na |
na |
na |
na |
| Skull_Fr |
Skull_Fracture |
0.12% |
9.5% |
40 |
0.240 |
12.4% |
35 |
0.404 |
35.9% |
37 |
0.497 |
| V55 |
Attention to artificial openings |
0.11% |
0.7% |
24 |
0.071 |
8.6% |
34 |
0.483 |
41.4% |
40 |
0.335 |
| V57 |
Care, rehabilitation procedures |
1.54% |
0.6% |
32 |
0.015 |
10.9% |
46 |
0.410 |
51.3% |
49 |
0.289 |
| V58 |
Aftercare |
0.45% |
1.4% |
38 |
0.122 |
4.2% |
37 |
0.457 |
23.3% |
47 |
0.407 |
| BDG1 |
Infectious and Parasitic Diseases |
0.65% |
1.7% |
36 |
0.130 |
8.0% |
51 |
0.485 |
30.9% |
55 |
0.402 |
| BDG2 |
Neoplasma |
1.79% |
2.3% |
61 |
0.151 |
6.7% |
78 |
0.400 |
29.4% |
102 |
0.337 |
| BDG3 |
Endocrine, Nutritional, Metabolic, and |
0.72% |
0.8% |
32 |
0.073 |
5.8% |
51 |
0.437 |
27.5% |
65 |
0.343 |
| BDG4 |
Diseases of Blood and Blood-Forming |
0.25% |
2.8% |
33 |
0.128 |
10.4% |
49 |
0.456 |
39.3% |
44 |
0.388 |
| BDG5 |
Mental Disorders |
1.82% |
0.2% |
41 |
0.024 |
2.8% |
51 |
0.325 |
23.3% |
56 |
0.374 |
| BDG6 |
Diseases of Nervous System and Sense |
0.89% |
1.0% |
44 |
0.090 |
5.0% |
57 |
0.477 |
29.3% |
78 |
0.358 |
| BDG7 |
Diseases of the Circulatory System |
0.85% |
2.8% |
52 |
0.128 |
14.5% |
64 |
0.480 |
44.1% |
90 |
0.382 |
| BDG8 |
Diseases of the Respiratory System |
0.66% |
1.6% |
40 |
0.101 |
10.7% |
54 |
0.480 |
33.3% |
63 |
0.423 |
| BDG9 |
Diseases of the Digestive System |
2.90% |
0.9% |
52 |
0.095 |
8.6% |
60 |
0.315 |
35.2% |
75 |
0.320 |
| BDG10 |
Diseases of the Genitourinary System |
2.02% |
0.2% |
39 |
0.045 |
2.8% |
59 |
0.430 |
23.8% |
82 |
0.259 |
| BDG11 |
Complications of Pregnancy and |
12.30% |
0.0% |
33 |
0.020 |
2.3% |
51 |
0.034 |
53.6% |
58 |
0.432 |
| BDG12 |
Diseases of Skin and Subcutaneous Tiss |
0.21% |
0.4% |
25 |
0.070 |
3.4% |
36 |
0.479 |
20.9% |
49 |
0.342 |
| BDG13 |
Musculoskeletal and Connective Tissue |
0.95% |
0.5% |
26 |
0.061 |
4.8% |
50 |
0.457 |
28.5% |
78 |
0.367 |
| BDG14 |
Congenital Anomalies |
0.28% |
0.9% |
33 |
0.092 |
6.0% |
56 |
0.334 |
28.6% |
85 |
0.345 |
| BDG16 |
Symptoms, Signs, and Ill-Defined |
0.42% |
2.0% |
35 |
0.111 |
8.1% |
50 |
0.457 |
40.8% |
60 |
0.359 |
| BDG17 |
Injury and Poisoning |
2.64% |
1.5% |
69 |
0.137 |
7.3% |
79 |
0.487 |
30.2% |
104 |
0.397 |
| BDG18 |
Factors Influencing Health Status |
0.25% |
2.9% |
27 |
0.480 |
4.6% |
42 |
0.534 |
24.3% |
64 |
0.393 |
Kroch E, Duan M, Terasawa E. CareScience Mortality Risk Model. In Mortality Measurement. February 2009. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/qual/mortality/KrochMort3.htm